RxDoctor Payments DataLook up a doctor →

Kelly Amann, DO

Family Medicine · Roy, UTNPI 1134116783

Payments from drug & device makers

$1,619,683in general payments, 2019–2025

Across 372 payments — averaging $4353.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$765K
  • AstraZeneca$362K
  • Genentech, Inc.$256K
  • Abbott$200K
  • Mylan Specialty L.p.$20K
  • Exact Sciences$13K
  • plus $4K from 40 others

What the payments were for

  • Food & beverage$3,703100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,619,683 in reported general payments places this provider in the 95th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah

Medicare billing

Part B allowed, 2024
$117,528
Medicare patients
252
Services billed
8,650

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide72$83,282
OzempicSemaglutide47$56,324
FarxigaDapagliflozin Propanediol53$55,044
TrulicityDulaglutide39$54,273
EliquisApixaban45$39,496
JardianceEmpagliflozin32$35,420
Janumet XrSitagliptin Phos/Metformin Hcl20$23,769
JanuviaSitagliptin Phosphate25$19,169
LinzessLinaclotide20$18,092
XareltoRivaroxaban18$14,873
TradjentaLinagliptin17$12,586
Fluticasone-SalmeterolFluticasone Propion/Salmeterol44$5,095
SymbicortBudesonide/Formoterol Fumarate21$5,066
Omeprazole218$4,622
Atorvastatin Calcium422$4,241

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$291$137,555111 claims
AstraZenecaFarxiga, Symbicort$362,080$60,10974 claims
Novo NordiskOzempic$80$56,32447 claims
Boehringer IngelheimJardiance, Tradjenta$86$48,00649 claims
MerckJanumet Xr, Januvia$68$42,93845 claims
PfizerEliquis$301$39,49645 claims
AbbVieLinzess$688$18,09220 claims
Johnson & JohnsonXarelto$108$14,87318 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 928 family medicine providers in Utah.

Other family medicine in Roy

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →